Allergen-specific immunotherapy in rhinitis patients is associated with milder COVID-19 symptoms and improved quality of life

Hanqiao Li, Renkang Wang, Benquan Yu, Jun He, Yibo Hu, Zuozhong Xie, Zi'an Xiao · 2026

Read Allergen-specific immunotherapy in rhinitis patients is associated with milder COVID-19 symptoms and improved quality of life by Hanqiao Li, Renkang Wang, Benquan Yu, Jun He, Yibo Hu, Zuozhong Xie, Zi'an Xiao (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13224361.txt.

Description

Hanqiao Li and co-authors report a 2026 Chinese cohort study of allergy patients who caught COVID-19 after lockdowns ended. Allergic rhinitis causes sneezing, congestion, and a runny nose, and its only treatment that changes the disease course is allergen-specific immunotherapy, a long course of controlled allergen doses. The question was whether that immune training also softened a later coronavirus infection.

Patients receiving immunotherapy faced lower risk of smell loss and sore throat once infected. Their whole-body symptoms also ended sooner, and their quality of life scored better than that of comparable patients. The authors read the pattern as a first signal that this immune modulation may extend protection beyond the original allergy.

Catalog record

CREATORHanqiao Li, Renkang Wang, Benquan Yu, Jun He, Yibo Hu, Zuozhong Xie, Zi'an Xiao
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE30 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13224361

Browse the full library · About the Tower of Babel